“Continuum of care” or “end-to-end care” are the new buzzwords in healthcare, but they’re not fleeting fads. In fact, the concepts mark a significant shift in healthcare, especially in the medical devices industry, which is used to treat isolated episodes of sickness with an implant before moving on to the next sick patient. On Thursday, […]
Medical device companies are slowly but surely recognizing that the emerging markets have specific needs that won’t be satisfied by recycling older models of pricey products meant for the first world. One evidence of that comes from Covidien PLC (NYSE:COV), which announced Thursday that it had opened a $45 million research and development center in the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Food and Drug Administration issued a warning to physicians and patients Monday about the Onyx Liquid Embolic System where the catheter used to deliver the liquid can get stuck inside the patient’s brain. The product – formerly made by Minnesota-based ev3 – is now part of Covidien which acquired the company in for $2.6 billion […]
Covidien announced Tuesday that it will introduce a new renal denervation treatment at a European conference in mid May, but nowhere in the press release does the Massachusetts device firm name the developer of the technology: Maya Medical, based in Campbell, California. For that you have to read the company’s quarterly report filed with the […]
The intense competition for the best treatment of runaway hypertension looks like it’s about to heat up. Word is that Massachusetts-based Covidien, which has been on a buying spree, is going to acquire early stage California medical technology company Maya Medical. Renal denervation is the potential solution for the 12 million people who can’t control […]
A week after an Israeli publication reported that Covidien was in advanced negotiations with Minnesota pulmonary device maker superDimension, the Massachusetts-based healthcare company announced that it is buying superDimension for about $300 million. The Minnesota company’s iLogic system diagnoses and treats lung cancer using electromagnetic navigation bronchoscopy. “Covidien’s strategy is to invest in clinically and […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Cleveland Clinic is touting itself as one of the few health centers in the country that’s offering a new stent from Covidien that’s designed to divert blood away from aneurysms. Clinic surgeons have implanted the Pipeline Embolization Device, a flexible stent that’s placed in the carotid artery, in 12 patients thus far, The Plain Dealer […]
Current medical news from today, including Covidien to separate pharmaceutical and medical device businesses, Amgen CEO Kevin Sharer to retire, and Costco takes EHRs to retail.
Former Covidien (NYSE:COV) executive Kenneth McBean has joined Cornerstone Therapeutics (NASDAQ:CRTX) to become president of the respiratory therapeutics company. The hire comes as Cornerstone puts more emphasis on its branded products and transitions away from sales of unbranded drugs. As Covidien’s vice president and general manager of Specialty Pharmaceuticals from March 2009 through last May, […]
Massachusetts Senator and GOP presidential hopeful Scott Brown told Covidien plc (NYSE:COV) employees that the impending medical device tax was “a wet blanket over the industry” when he toured the med-tech giant’s headquarters in Mansfield, Mass., yesterday. An active challenger of the impending medical device tax, Brown’s latest legislation aimed at repealing the bill was […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program today. “The board’s approval of this share repurchase program reflects its confidence in the continued growth of Covidien’s business, our sustainable free cash flow and our commitment to enhance shareholder value,” president & CEO José Almeida said in a press release. The […]
Covidien Plc. (NYSE:COV) will likely beef up its overseas workforce, CEO Joe Almeida told attendees at a Boston meeting of medical device executives today. “Slightly less than half of our revenues come from outside the U.S., so we need more people in places like the UK and Singapore,” Almeida said. Almeida insisted that the jobs […]
Shares of Covidien plc (NYSE:COV) rose more than 4 percent this morning after the company announced a third-quarter profit bump of 47.0 percent and a top-line boost of 14.1 percent. Wall Street liked the 22 percent sales boost added by the Mansfield, Mass.-based health products maker’s workhorse medical device segment during the three months ended […]
Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare. Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco […]
The flurry of moves Covidien plc (NYSE:COV) made in 2010 are starting to pay off for the Mansfield, Mass.-based medical products conglomerate. New business from its $2.6 billion ev3 acquisition helped Covidien double its vascular unit’s sales during the three months ended March 25, posting revenues of $333 million, up 103 percent over the same […]